期刊文献+

c-Met信号通路及其抑制剂的研究进展 被引量:5

Research progress of c-Met signaling pathway and antagonists
下载PDF
导出
摘要 c-Met和肝细胞生长因子(HGF)在很多肿瘤细胞组织中高表达。c-Met信号通路的活化引起一系列的信号级联放大反应,导致了肿瘤细胞的生长、增殖、侵袭和凋亡减少。HGF是c-Met的配体,参与并影响肿瘤微环境的形成。该文就HGF如何活化c-Met及其下游的信号通路、c-Met与其他受体介导的信号通路间的串话对耐药性的影响以及针对HGF和c-Met信号通路的抑制剂的研究进展进行综述。 High expression of c-MET and hepatocyte growth factor (HGF) is frequently found in tumor cells. The activation of c-Met signaling pathway triggers a series of signaling cascade reaction, leads to the growth, proliferation and invasion of tumor cells, and exempts tumor cells from apoptosis. HGF is the ligand of c-Met, and affects the formation of microenvironment of tumor cells. How HGF activates c-Met and the signaling pathway of its downstream components, and how the crosstalk of the signaling pathway mediated by c-Met and the other receptors affects the drug resistance are introduced in this paper. Besides, the research progress of HGF and c-Met signaling pathway inhibitors is also reviewed.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第8期1167-1170,共4页 Journal of Shanghai Jiao tong University:Medical Science
关键词 c—Met 肝细胞生长因子 c—Met抑制剂 信号通路 c-Met hepatocyte growth factor c-Met antagonists signaling pathway
  • 相关文献

参考文献32

  • 1Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer[J]. Nat Rev Cancer, 2004, 4( 11 ) : 839 - 849. 被引量:1
  • 2Li Y, Zhang S, Tang Z, et al. Silencing of c-Met by RNA interfer- ence inhibits the survival, proliferation, and invasion of nasopharyn-geal carcinoma cells[J]. Turnout Biol, 2011, 32 (6): 1217 - 1224. 被引量:1
  • 3Bladt F, Riethmacher D, Isenmann S, et al. Essential role for the c-Met receptor in the migration of myogenic precursor cells into the limb bud[J]. Nature, 1995, 376(6543): 768 -771. 被引量:1
  • 4Wang J, Gui Z, Deng L, et al. c-Met upregulates aquaporin 3 expression in human gastric carcinoma ceils via the ERK signalling pathway[J]. Cancer Lett, 2012, 319 (1): 109-117. 被引量:1
  • 5Knudsen BS, Edlund M. Prostate cancer and the met hepatocyte growth factor receptor[J]. Adv Cancer Res, 2004, 91 : 31 -67. 被引量:1
  • 6Matsumura A, Kubota T, Taiyoh H, et al. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 routine cells[J]. Int J Oncol, 2013, 42(2) : 535 -542. 被引量:1
  • 7Gibney GT, Aziz SA, Camp RL, et al. c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma [J]. Ann Oncol, 2013, 24(2): 343 -349. 被引量:1
  • 8Sgambato A, Casaluce F, Malone P, et al. The c-Met inhibitors: a new class of drugs in the battle against advanced nonsmall-cell lung cancer[J]. CurrPharm Des, 2012, 18(37): 6155 -6168. 被引量:1
  • 9Hasina R, Matsumoto K, Matsurnoto-Taniura N, et al. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line[Jl. Br J Cancer, 1999, 80(11): 1708-1717. 被引量:1
  • 10Wagner AJ, Goldberg JM, Dubois SG, et al. Tivantinib (ARQ 197 ) , a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors:results of a multicenter phase 2 trial[J]. Cancer, 2012, 118(23): 5894 -5902. 被引量:1

二级参考文献3

共引文献9

同被引文献44

  • 1赵庆洪,汪宝林,陈国玉,高蓓,闻浩,张建平.联合检测胃癌患者外周血sCD44v5和CD44v5含量的意义[J].江苏医药,2006,32(8):723-724. 被引量:2
  • 2Zheng S, Vuitton L, Sheyhidin I, et al. Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and en- vironmental risk factors[J]. Eur J Gastroenterol Hepatol, 2010, 22(8): 917-925. 被引量:1
  • 3Merritt WM,Kamat AA,Hwang JY,et al.Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial can- cer [J]. Cancer Biol Ther, 2010, 10(12):1306-1314. 被引量:1
  • 4Franklin S,Pho T,Abreo FW,et al. Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers [J]. Arch Otolaryngol Head Neck Surg, 1999, 125(2):177-182. 被引量:1
  • 5Zaanan A,Laurent-Puig P,Taieb J.MET signalling pathway and its therapeutic implications in gastrointestinal cancers[J].Bull Cancer, 2014,101(1):25-30. 被引量:1
  • 6Eder JP,Vande WGF,Boerner SA,et al. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer [J]. Clin Cancer Res, 2009, 15(7):2207-2214. 被引量:1
  • 7Matsumura A,Kubota T,Taiyoh H,et al. HGF regulates VEGF ex- pression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells [J]. Int J Oncol, 2013, 42 (2): 535-542. 被引量:1
  • 8Wang J, Gui Z, Deng L, et al. c-Met upregulates aquaporin 3 ex- pression in human gastric carcinoma cells via the ERK signalling pathway [J]. Cancer Lett, 2012, 319(1): 109-117. 被引量:1
  • 9Grugan KD,Miller CG,Yao Y,et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion [J]. Proc Natl Acad Sci U S A, 2010, 107(24): 11026-11031. 被引量:1
  • 10Uardi JM, Mochida S, Sheng ZH. SNAPIN : a SNARE-associated protein implicated in synaptic transmission [ J ]. Nat Neurosci, 1999,2(2) :119 -124. 被引量:1

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部